About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Chicago | 351 Studies

Clinical Trials HypertensionChicago

Hypertension Clinical Trials in Chicago

Find 351 clinical trials for hypertension near Chicago, Illinois. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 351 trials

CompletedContrast Enhanced PA Pressure MeasurementsPulmonary hypertension (PH) is an abnormal increase of the pressure inside the lung circulation. This condition can be caused by many different diseases.NCT06240871·Chicago, Illinois CompletedPravastatin for Prevention of PreeclampsiaThe primary purpose of this pilot study is to determine the pharmacokinetic (PK) parameters and collect preliminary safety data for pravastatin when used as a prophylactic daily…NCT01717586·Chicago, Illinois and 2 others

Hypertension Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsThis was a 4-week, multicenter, double-blind, placebo-controlled, randomized, parallel-group study to determine the antihypertensive dose range, efficacy, safety and tolerability…NCT00255528·Little Rock, Arkansas and 30 others

CompletedEffect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionEvaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressureNCT00060931·Birmingham, Alabama and 118 others

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

RecruitingA Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDThis is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated…NCT07333183·Santa Barbara, California and 12 others

CompletedPulmonary Hypertension, Hypoxia and Sickle Cell DiseaseThe study will look at the risk factors for pulmonary hypertension (high blood pressure in the lungs) in children and adolescents with sickle cell anemia (SCA) and examine the…NCT00495638·Washington D.C., District of Columbia and 6 others

RecruitingInteractive Computer-adaptive Chronic Kidney Disease Education ProgramThe goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney…NCT06364358·Chicago, Illinois

TerminatedA Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary HypertensionThe purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary…NCT04271475·La Jolla, California and 167 others

CompletedHypertension Management Using Remote Patient MonitoringA longer-term follow-up of patients with remote patient monitoring ordered from the initial six pilot primary care clinics (from the prior study periods: Study 1 and Study 2) will…NCT05562921·Chicago, Illinois

CompletedEfficacy and Safety of a Quadruple Ultra-low-dose Treatment for HypertensionTo investigate, in a double-blind randomized controlled trial, whether initiating treatment with ultra-low-dose quadruple-combination therapy ("LDQT") will lower office blood…NCT03640312·Bloomingdale, Illinois and 1 other

CompletedTargeting of UnControlled Hypertension in Emergency DepartmentThe proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly…NCT03749499·Chicago, Illinois

TerminatedPhase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAHThis is a multi-center, randomized, double-blind, controlled, Phase 2 study to assess the safety, tolerability, and efficacy of pemziviptadil (PB1046) at the optimally titrated…NCT03556020·Mobile, Alabama and 25 others

CompletedNegative Pressure Applied by the Equinox MPD for Severe Open Angle GlaucomaThis is a prospective, non-significant risk, controlled, randomized, multi-center, masked, feasibility study to evaluate the safety and IOP-lowering effectiveness of negative…NCT04632329·Chicago, Illinois and 2 others

TerminatedA Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial HypertensionThis is a multi-center, open-label study of sitaxsentan sodium 100 mg taken orally once daily by subjects with PAH until sitaxsentan, in a particular country or region, is…NCT00811018·Birmingham, Alabama and 90 others

RecruitingMulti-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionMOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease…NCT06911632·Birmingham, Alabama and 36 others

RecruitingE3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension ControlThis study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics…NCT06899750·Chicago, Illinois

UnknownA Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisA randomized, double-blind, placebo-controlled dose escalation study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary fibrosis on…NCT05747508·Phoenix, Arizona and 22 others

CompletedAn 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic HypertensionThe purpose of the study is to evaluate dose response of blood pressure lowering for 4 doses of AHU377, given once daily (50 mg, 100 mg, 200 mg and 400 mg) in combination with a…NCT01281306·Clearwater, Florida and 89 others

CompletedFREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who were currently receiving approved therapy for their PAH…NCT00325442·Birmingham, Alabama and 71 others

PreviousPage 2 of 18Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia